Saint Michael's Recognized for Participation in Clinical Trial

Saint Michael's Recognized for Participation in Clinical Trial

Saint Michael’s Medical Center has been recognized by the Duke Clinical Research Institute (DCRI) for enrolling the highest number of participants in the Northeast in an ongoing clinical trial seeking to improve the outcomes of patients with congestive heart failure. Saint Michael’s is one of 160 hospitals nationwide participating in the CONNECT-HF clinical trial, which […]

Aurinia Completes Enrollment of AURORA, its Phase 3 Clinical Trial for the Treatment of Lupus Nephritis

Aurinia Completes Enrollment of AURORA, its Phase 3 Clinical Trial for the Treatment of Lupus Nephritis

VICTORIA, British Columbia — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has completed enrollment for the AURORA Phase 3 trial ahead of schedule. The target enrollment of 324 patients was surpassed due to high patient demand with 358 lupus nephritis (LN) patients […]

Aldeyra Therapeutics Announces Positive Mesothelioma Investigator-Sponsored Clinical Trial Results Presented at …

LEXINGTON, Mass., Sept. 25, 2018 /PRNewswire/ — Aldeyra Therapeutics, Inc. (Aldeyra) (NASDAQ :ALDX ), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced positive top-line results from the MESO-2 investigator-sponsored Phase 1/2 clinical trial of ADX-1612 (ganetespib) in patients with pleural malignant mesothelioma. ADX-1612, […]

Two Gemphire Execs Caught in Layoffs After Clinical Trial Setbacks

Two Gemphire Execs Caught in Layoffs After Clinical Trial Setbacks

Xconomy Detroit/Ann Arbor —  Gemphire Therapeutics is laying off five, including two executives, as the company grapples with clinical trial setbacks for its lead drug candidate. Chief Financial Officer Jeffrey Mathieson and Chief Medical Officer Lee Golden have left Livonia, MI-based Gemphire (NASDAQ: GEMP), though the company says Mathieson agreed to consult with the company […]

Prostate cancer clinical trial seeking Rx approach answers for survival and quality of life

Prostate cancer clinical trial seeking Rx approach answers for survival and quality of life

IMAGE: Dr. Scott Delacroix. view more  Credit: LSU Health New Orleans New Orleans, LA – LSU Health New Orleans Scott Cancer Center has enrolled the first patients in the United States in a National Cancer Institute/Southwest Oncology Group clinical trial for men whose prostate cancer has spread. The Phase III multi-center trial will compare the outcomes […]

TrialScope Unveils New Clinical Trial Transparency and Health Literacy Service for Sponsors

JERSEY CITY, N.J., Sept. 25, 2018 /PRNewswire/ — TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced the launch of its Clinical Trial Transparency Service (CTTS). This transparency and health literacy management solution enables clinical trial sponsors to engage with patients, healthcare professionals, researchers and the public via a dedicated clinical trial […]

Veeva Introduces Single Application to Manage All Clinical Trial Data

Veeva Introduces Single Application to Manage All Clinical Trial Data

Veeva Systems has announced a next-generation cloud application to streamline clinical data management and accelerate study execution. Veeva Vault CDMS eliminates the need for multiple tools with a single clinical data management application that combines coding, EDC, data cleaning, and reporting. Companies can now have one application that allows them to manage study build through execution […]

Catabasis Pharmaceuticals Initiates Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular …

Catabasis Pharmaceuticals Initiates Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep 25, 2018–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the initiation of PolarisDMD, the Company’s Phase 3 trial for edasalonexent in Duchenne muscular dystrophy (DMD). Edasalonexent inhibits NF-kB, which is the key link between loss of dystrophin and disease pathology and plays a fundamental role in the initiation and progression […]

Catabasis Pharma (CATB) Commences hase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular …

Catabasis Pharma (CATB) Commences hase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular …

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) today announced the initiation of PolarisDMD, the Company’s Phase 3 trial for edasalonexent in Duchenne muscular dystrophy (DMD). Edasalonexent inhibits NF-kB, which is the key link between loss of dystrophin and disease pathology and plays a fundamental […]

1 2 3 165